A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Επικοινωνία Submitted by Δημήτρης Σπάχος on Πέμ, 12/03/2020 - 20:14
